Research progress on the treatment of bullous pemphigoid with Dupilumab
In recent years, there have been many reports on the use of Dupilumab in the treatment of bullous pemphigoid. Dupilumab specifically binds to the subunit alpha of interleukin 4 receptor (IL-4Rα), blocking the signal transduction of interleukin (IL)-4 and IL-13, inhibiting the proliferation of B cell...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Chinês |
| Vydáno: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology
2024-08-01
|
| Edice: | Pifu-xingbing zhenliaoxue zazhi |
| Témata: | |
| On-line přístup: | http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.08.010 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|